Executive Leadership

Dr. Sri Navaratnam

Dr. Sri Navaratnam, President and CEO

Dr. Navaratnam has been President and CEO since January 1, 2014. Her efforts are focused on supporting the Vision and Mission of CancerCare Manitoba and implementing the six strategic priorities outlined in Delivering Excellence: 2016-2021 Manitoba Cancer Plan. This includes being a champion for the expanded scope of research at CCMB, in partnership with the University of Manitoba, and working with regional health leaders as co-chair of the provincial cancer patient journey initiative.

During her 20-year career as a Medical Oncologist at CCMB, Dr. Navaratnam has held leadership positions within CancerCare Manitoba as the Department Head of Medical Oncology and Hematology and in other affiliated organizations: Medical Director of Oncology at the Winnipeg Regional Health Authority and as Section Head of Hematology/Oncology, Department of Internal Medicine at the University of Manitoba.

Dr. Navaratnam obtained her Ph.D. from the Department of Pharmacology, University of Manitoba, in 1990 and upon completing her training in Internal Medicine, continued with subspecialty training in Medical Oncology at CancerCare Manitoba and the University of Manitoba. Dr. Navaratnam received her undergraduate medical training at the University of Jaffna, Sri Lanka.

Dr. Arbind Dubey, Chief Medical Officer

Dr. Dubey took on the role of Chief Medical Officer on September 15, 2023. He joined CancerCare Manitoba in 2014 as a Radiation Oncologist in the Department of Radiation Oncology, as well as an Associate Professor in the Department of Radiology, University of Manitoba.

His current administrative roles include Chair of the GU DSG since 2016, and member of the fellowship committee and PGME committee for Radiation Oncology. During his career, he has led various initiatives to develop radiation protocols and implement new techniques in radiation treatment. Dr. Dubey is involved in multiple research projects and is the PI on several clinical trials. Dr. Dubey holds the Physician Executive certification through the Canadian Medical Association obtained in 2013, and has since completed various courses and leadership competencies through the Physician Management Institute and Physician Leadership Institute with the CMA.

Dr. Dubey brings the compassion of caring for Manitobans with cancer and blood disorders to the role, as well as the experience and awareness of our current health system and the importance of the well-being of all healthcare providers.

Mr. Ken N. Borce, Chief of Clinical Operations

Mr. Ken N. Borce was appointed Chief of Clinical Operations in June 2022. Mr. Borce focuses on clinical and operational excellence in order to deliver sustainable and exceptional cancer services to Manitobans. He leads and oversees the Community Oncology program, Outpatient Clinic program, Radiation Oncology program, Patient and Family Support Services, Psychosocial Oncology, and Systemic Therapy program.

Prior to his appointment, Mr. Borce was a civilian senior officer at the Winnipeg Police Service as communications division head. He also held various positions in the health-care system such as leadership roles in the Critical Care program, Long Term Care program, and Personal Care program.

Mr. Borce is a Registered Nurse and completed his Bachelor of Science (Nursing) at the University of Santo Tomas, Manila, Philippines. He attended the University of Winnipeg where he completed his Bachelor of Science (Biochemistry) and Asper School of Business at the University of Manitoba where he earned his Master of Business Administration (MBA).

Dr. Donna Turner, Chief of Population Oncology

Dr. Donna Turner has held the role of Chief of Population Oncology since 2007. This portfolio is comprised of Epidemiology, the Manitoba Cancer Registry, Screening Programs (BreastCheck, CervixCheck and ColonCheck) and Underserved Populations.

Dr. Turner’s research interests complement her administrative responsibilities and revolve around the use of population-based cancer data as a means of informing cancer control activities. She works in various aspects of cancer control research – from prevention to early detection to diagnosis and treatment to outcomes – using the population-based data resources of the provincial health department and CancerCare Manitoba. She is involved in several national and international cancer surveillance, epidemiology and health services research efforts, including the International Cancer Benchmarking Partnership, CONCORD, and work supported by the Canadian Partnership Against Cancer (CPAC), and the Canadian Institutes for Health Research (CIHR).

Dr. Turner graduated from the University of Victoria’s Health Information Science program, received her Ph.D. from the University of Alberta and completed a postdoctoral fellowship with the Manitoba Centre for Health Policy. She is an Associate Professor in the Department of Community Health Sciences at the University of Manitoba.

Mr. Brent Gibson, Chief of Corporate Services and Finance

Mr. Brent Gibson was appointed Chief of Corporate Services and Finance in June 2020. Brent’s focus is on the overall health and performance of the corporate operations required for CCMB to provide excellent services to Manitobans. He is responsible for leadership in such areas as finance, human resources, facilities, information systems, business development, procurement, and other corporate functions, including corporate operations of the Research Institute.

Before joining CCMB, Brent served as the Executive Director, Corporate and Financial Services for the Community Safety Division of Manitoba Justice. He also worked for over ten years in progressively senior leadership roles with Manitoba Growth, Enterprise and Trade, including serving as A/ Chief Financial Officer for Entrepreneurship Manitoba, a special operating agency of the Manitoba government.

Brent is a Chartered Professional Accountant (CPA, CGA) and attended the University of Manitoba completing a Bachelor of Commerce (Honours in Finance and Management Information Systems) and a Bachelor of Arts (History). He also holds a Master of Business Administration (MBA) from Laurentian University in Ontario.

Mr. Jim Slater, Chief of Research Administration and Operations

Mr. Slater has been the Chief of Research Administration and Operations since April 2023.

He is the former CEO of Diagnostic Services Manitoba and COO and Provincial Lead of Health Support Services, Shared Health. Following this, he became the Chief Provincial Diagnostics Officer of the Provincial Health Services Authority in B.C. He brings experience as a health system specialist and consultant.

Mr. Slater brings strong leadership experience and understanding of Canada’s health care system to the role with expertise in diagnostics, precision medicine, value-based health care, innovation and resource stewardship, research and business development.

Executive Expense Reports

In keeping with recent amendments to the Regional Health Authorities Act of Manitoba, CancerCare Manitoba will publish the expenses paid to and on behalf of the Chief Executive Officer (CEO). Reports on CEO expenses will be published on an annual basis.

CCMB is disclosing expenses as approved by CCMB's Chair of the Board of Directors. The disclosure supports CCMB's commitment to accountability and transparency to Manitobans.

CCMB CEO expenses

Financial Report for 2022

Dr. Sri Navaratnam
(from 2022/04/01 to 2023/03/31)

Financial Report for 2021

Dr. Sri Navaratnam
(from 2021/04/01 to 2022/03/31)

Financial Report for 2020

Dr. Sri Navaratnam
(from 2020/04/01 to 2021/03/31)

Financial Report for 2019

Dr. Sri Navaratnam
(from 2019/04/01 to 2019/03/31)

Financial Report for 2018

Dr. Sri Navaratnam
(from 2018/04/01 to 2019/03/31)

Financial Report for 2017

Dr. Sri Navaratnam
(from 2017/04/01 to 2018/03/31)

Financial Report for 2016

Dr. Sri Navaratnam
(from 2016/04/01 to 2017/03/31)

Financial Report for 2015

Dr. Sri Navaratnam
(from 2015/04/01 to 2016/03/31)

Financial Report for 2014

Dr. Sri Navaratnam
(from 2014/04/01 to 2015/03/31)

Financial Reports for 2013

Dr. Dhali Dhaliwal
(from 2013/04/01 to 2013/12/31)

Dr. Sri Navaratnam
(from 2014/01/01 to 2014/03/31)